Schoenherr has advised Enterprise Investors on the acquisition of a 100% stake in Centrum Medyczne Internus. DLA Piper reportedly advised the sellers.
Herbst Kinsky Advises Biogena on EUR 10 Million Bond Issuance
Herbst Kinsky has advised Biogena on its EUR 10 million bond issuance.
NKO Partners and Joksovic, Stojanovic & Partners Advise on Levante HC's Acquisition of Megapharm
NKO Partners has advised Levante HC on the acquisition of Megapharm Beograd. Joksovic, Stojanovic & Partners advised Megapharm.
Intellectual Property – A Permitted Monopoly in the Pharmaceutical Industry
As a driving force behind human progress, Intellectual Property represents property arising from the creative, inventive, or innovative activity of a human being. Such activities are protected by permitted monopolies made possible through Intellectual Property Rights. A particular challenge lies in finding a balance between protecting innovation through Intellectual Property Rights and the public interest—especially in industries where this balance plays a significant role, such as the pharmaceutical industry.
Greenberg Traurig Advises American Heart of Poland Group on EUR 200 Million Second-Lien Financing from CVC Credit Funds
Greenberg Traurig has advised American Heart of Poland Group on EUR 200 million second-lien financing from CVC Credit Funds, arranged alongside the group’s existing senior syndicated facility of approximately PLN 1.9 billion. Linklaters and Allen Overy Shearman Sterling reportedly advised on the transaction as well.
Schoenherr and Dorda Advise on Sale of Hi.health to Pliant
Schoenherr has advised Austrian health‑tech startup Hi.health and its shareholders on the sale of the business to Pliant. Studio Legal and Dorda advised Pilant.
Schoenherr and Gessel Advise on Acquisition of Medical Mazella
Schoenherr has advised BPM Capital on providing mezzanine financing for a management buy-in acquisition of Medical Mazella while Gessel advised BNP Paribas Bank Polska on its co-investment in the buyout. Reportedly, Compliance Partners advised co-investor MedPack and Misiewicz, Mosek i Partnerzy advised Medical Mazella.